icer
releas
draft
evid
report
incorpor
initi
input
patient
clinician
stakehold
apprais
compar
valu
effect
obetichol
acid
intercept
pharmaceut
inc
nonalcohol
steatohepat
nash
line
extens
allow
clinician
respond
pandem
public
comment
accept
draft
june
revis
evid
report
discuss
public
meet
one
icer
independ
evid
apprais
committe
provision
schedul
august
draft
interim
pend
input
taken
final
stakehold
regist
meet
submit
formal
comment
request
make
oral
comment
email
hope
expand
timefram
enabl
stakehold
instead
focu
meet
need
patient
commun
nation
emerg
said
statement
timelin
updat
post
icer
websit
